Westfield Capital Management’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,368,720
| Closed | -$116M | – | 268 |
|
|
2019
Q4 | $116M | Sell |
1,368,720
-5,099,682
| -79% | -$340M | 0.83% | 33 |
|
|
2019
Q3 | $323M | Buy |
6,468,402
+1,821,394
| +39% | +$72.7M | 2.59% | 1 |
|
|
2019
Q2 | $169M | Sell |
4,647,008
-643,473
| -12% | -$21M | 1.28% | 14 |
|
|
2019
Q1 | $148M | Buy |
5,290,481
+685,762
| +15% | +$16.2M | 1.13% | 19 |
|
|
2018
Q4 | $88.1M | Buy |
4,604,719
+817,508
| +22% | +$19M | 0.75% | 43 |
|
|
2018
Q3 | $113M | Buy |
3,787,211
+506,028
| +15% | +$19.1M | 0.8% | 31 |
|
|
2018
Q2 | $120M | Buy |
3,281,183
+251,572
| +8% | +$8.17M | 0.9% | 22 |
|
|
2018
Q1 | $99.8M | Buy |
3,029,611
+125,136
| +4% | +$3.91M | 0.77% | 35 |
|
|
2017
Q4 | $79.4M | Buy |
2,904,475
+427,697
| +17% | +$13.2M | 0.61% | 51 |
|
|
2017
Q3 | $91.7M | Buy |
2,476,778
+445,419
| +22% | +$16.4M | 0.7% | 41 |
|
|
2017
Q2 | $77.2M | Buy |
2,031,359
+1,837,359
| +947% | +$81.8M | 0.66% | 48 |
|
|
2017
Q1 | $9.49M | Buy |
+194,000
| New | +$8.85M | 0.08% | 209 |
|
|
2014
Q4 | – | Sell |
-16,900
| Closed | -$377K | – | 340 |
|
|
2014
Q3 | $377K | Sell |
16,900
-5,300
| -24% | -$135K | ﹤0.01% | 286 |
|
|
2014
Q2 | $645K | Buy |
+22,200
| New | +$593K | ﹤0.01% | 281 |
|
Other funds holding MDCO
Westfield Capital Management's MDCO Position: Q1 2020 in Review
Westfield Capital Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,368,720 shares — an estimated $116M sold.
Westfield Capital Management first reported a position in MDCO in Q2 2014 and held it in 14 quarters. The position peaked at $323M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Westfield Capital Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Westfield Capital Management sold 1,368,720 Medicines Co shares in Q1 2020, an estimated $116M.
- Westfield Capital Management first reported a position in Medicines Co in Q2 2014 and held it in 14 quarters.
- Westfield Capital Management's Medicines Co position peaked at $323M in Q3 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Westfield Capital Management's 13F filing for Q1 2020, filed 14 May 2020.